# DermaPharm A/S – FDA Inspection, Sep 19, 2019

Source: https://www.keypedia.com/records/fda_inspections/dermapharm-as/412944e0-af0e-40a6-b95d-2f6e47c32bd4
Source feed: FDA_Inspections

> FDA inspection 1102220 of DermaPharm A/S, September 19, 2019. Classification: Official Action Indicated (OAI). 3 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102220
- Company Name: DermaPharm A/S
- Inspection Date: 2019-09-19
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3
- Enforcement Type: WARNING_LETTER

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jennifer-lalama/5ebc4da1-62ac-4b15-89a8-e18b0606e0ff)

Company: https://www.keypedia.com/companies/dermapharm-as/6bea9859-5e4e-4d9d-a74c-14600a77cf0f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c